Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
Quick Stats
Jan 30, 202654.0
AI Score
HOLD0.71
Volume Ratio
Feb 12, 2026
Next Earnings
16
+ve Days (30d)
11
-ve Days (30d)
GRCE Stock Summary
Last updated Jan 30, 2026
GRCE is currently trading at $3.63, positioned above its 200-day moving average of $3.11, indicating a long-term uptrend. The stock has a 52-week range of $1.75 to $3.938.
Technical Analysis: The 50-day moving average stands at $3.44, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 52.324, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.102, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GRCE at 54.0/100 with a HOLD recommendation.
GRCE (Grace Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 52.324 |
| CMF (20) | -0.102 |
| ROC (10) | -0.275 |
| ADX (14) | 27.886 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.056 |
| AROONOSC (14) | 14.286 |
| WILLAMS %R (14) | -57.249 |
| MFI (14) | 39.313 |
GRCE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GRCE Price vs Max Options Open Interest
GRCE Max Change In Options Open Interest
GRCE Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRCE Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRCE Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRCE Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Grace Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
GRCE Moving Averages Analysis
Grace Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Grace Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
GRCE (Grace Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.67 |
| 20 | 3.66 |
| 30 | 3.58 |
| 50 | 3.44 |
| 100 | 3.26 |
| 200 | 3.11 |
GRCE Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 56.2 million |
| Earnings/Share ($) | -0.53 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.262 |
| EPS Estimate Next Year ($) | -1.2845 |
| WallStreet Target Price ($) | 12.108 |
| Most Recent Quarter |